Aug 8 (Reuters) - Abeona Therapeutics Inc ABEO.O :
* ABEONA THERAPEUTICS REPORTS SECOND QUARTER 2023 FINANCIAL
RESULTS
* ON TRACK FOR BIOLOGICS LICENSE APPLICATION (BLA)
SUBMISSION IN
Q3 OF 2023
* CASH ON HAND PLUS PROCEEDS FROM REGISTERED DIRECT OFFERING
PROJECTED TO FUND OPERATIONS INTO Q4 OF 2024
* CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM
INVESTMENTS TOTALED $37.1 MILLION AS OF JUNE 30, 2023
* QTRLY NET LOSS PER SHARE $0.92
* Q2 EARNINGS PER SHARE VIEW $-0.68 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbNNYRL
Further company coverage: ABEO.O